Sanofi SA

Press Release: Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli

03 Oct 2023 00:30:00 By Nasdaq GlobeNewswire

Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review

26 Sep 2023 00:30:00 By Nasdaq GlobeNewswire

Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

25 Sep 2023 02:00:00 By Nasdaq GlobeNewswire

Press Release: Availability of the Q3 2023 Memorandum for modelling purposes

22 Sep 2023 00:30:00 By Nasdaq GlobeNewswire

Press Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change

19 Sep 2023 01:30:00 By Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - August 2023

11 Sep 2023 13:02:14 By Nasdaq GlobeNewswire

Press Release: Sanofi announces changes to its Executive Committee

31 Aug 2023 00:30:00 By Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - July 2023

15 Aug 2023 14:24:04 By Nasdaq GlobeNewswire

Press Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease

03 Aug 2023 14:21:34 By Nasdaq GlobeNewswire

Press release: Online availability of Sanofi’s half-year financial report for 2023

28 Jul 2023 06:22:14 By Nasdaq GlobeNewswire

Press Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment

28 Jul 2023 00:32:00 By Nasdaq GlobeNewswire

Press Release: Solid Q2 performance and strong pipeline momentum, Full-year 2023 business EPS guidance raised

28 Jul 2023 00:30:00 By Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares – June 2023

18 Jul 2023 11:29:03 By Nasdaq GlobeNewswire

Press Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease

17 Jul 2023 12:00:00 By Nasdaq GlobeNewswire

Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease

29 Jun 2023 00:30:00 By Nasdaq GlobeNewswire

Press Release: Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligand monoclonal antibody

27 Jun 2023 00:30:00 By Nasdaq GlobeNewswire

Press Release: ALTUVIIIO late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosing

25 Jun 2023 09:30:00 By Nasdaq GlobeNewswire

Press Release: Availability of the Q2 2023 Memorandum for modelling purposes

22 Jun 2023 00:30:00 By Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - May 2023

20 Jun 2023 12:43:26 By Nasdaq GlobeNewswire

Press Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim

20 Jun 2023 00:30:00 By Nasdaq GlobeNewswire